RecallRadar

FDA Drug recall D-1135-2015

Divalproex Sodium Extended-Release Tablets, USP, (valproic acid activity), 250 mg, 100 count (NDC 55111-533-01) and 500 count (NDC 55111-53…

On 2015-06-24 the FDA classified a Class II recall of Divalproex Sodium Extended-Release Tablets, USP, (valproic acid activity), 250 mg, 100 count (NDC 55111-533-01) and 500 count (NDC 55111-53… by Dr Reddy S Laboratories, citing failed Dissolution Specifications; exceeded specification at the 9 hour time point.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-1135-2015
ClassificationClass II
Statusterminated
Initiated2015-05-22
Published2015-06-24
Last updated2026-09-13 11:51 UTC
CompanyDr Reddy S Laboratories
DistributionUS

Product

Divalproex Sodium Extended-Release Tablets, USP, (valproic acid activity), 250 mg, 100 count (NDC 55111-533-01) and 500 count (NDC 55111-533-05) bottles, Rx Only, Mfd. By. Dr. Reddy's Laboratories Limited, Bachupally 500 090 India

Reason

Failed Dissolution Specifications; exceeded specification at the 9 hour time point

Identifiers

ndc55111-533-30
ndc55111-533-60
ndc55111-533-01
ndc55111-533-05
ndc55111-533-79
ndc55111-533-78
code_info100 count bottle - Lot #C307859, exp 09/2015; 500 count bottle - Lot #C307859 and Lot# C307812, exp 09/2015

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1135-2015%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.